The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies
Open accessAbstract
The dynamics of viral shedding and symptoms following influenza virus infection are key factors when considering epidemic control measures. The authors reviewed published studies describing the course of influenza virus infection in placebo-treated and untreated volunteers challenged with wild-type influenza virus. A total of 56 different studies with 1,280 healthy participants were considered. Viral shedding increased sharply between 0.5 and 1 day after challenge and consistently peaked on day 2. The duration of viral shedding averaged over 375 participants was 4.80 days (95% confidence interval: 4.31, 5.29). The frequency of symptomatic infection was 66.9% (95% confidence interval: 58.3, 74.5). Fever was observed in 37.0% of A/H1N1, 40.6% of A/H3N2 (p = 0.86), and 7.5% of B infections (p = 0.001). The total symptoms scores increased on day 1 and peaked on day 3. Systemic symptoms peaked on day 2. No such data exist for children or elderly subjects, but epidemiologic studies suggest that the natural history might differ. The present analysis confirms prior expert opinion on the duration of viral shedding or the frequency of asymptomatic influenza infection, extends prior knowledge on the dynamics of viral shedding and symptoms, and provides original results on the frequency of respiratory symptoms or fever.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Influenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213
Strategies for mitigating an influenza pandemic
Ferguson, N. M., Cummings, D. A. T., Fraser, C., Cajka, J. C., Cooley, P. C., & Burke, D. S. (2006) · Nature · doi:10.1038/nature04795 · Cited by 2,187
Self-citationStrategies for containing an emerging influenza pandemic in Southeast Asia
Ferguson, N. M., Cummings, D. A. T., Cauchemez, S., Fraser, C., Riley, S., Meeyai, A., Iamsirithaworn, S., & Burke, D. S. (2005) · Nature · doi:10.1038/nature04017 · Cited by 1,816
Self-citationFactors that make an infectious disease outbreak controllable
Fraser, C., Riley, S., Anderson, R. M., & Ferguson, N. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307506101 · Cited by 1,144
Self-citationMitigation strategies for pandemic influenza in the United States
Germann, T. C., Kadau, K., Longini, I. M., & Macken, C. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601266103 · Cited by 1,047
Review of Aerosol Transmission of Influenza A virus
Tellier, R. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1211.060426 · Cited by 803
Transmissibility of 1918 pandemic influenza
Mills, C. E., Robins, J. M., & Lipsitch, M. (2004) · Nature · doi:10.1038/nature03063 · Cited by 796
Ecological and immunological determinants of influenza evolution.
Ferguson, N. M., Galvani, A. P., & Bush, R. M. (2003) · Nature · doi:10.1038/nature01509 · Cited by 746
Self-citationTransmission of influenza A in human beings
Brankston, G., Gitterman, L., Hirji, Z., Lemieux, C., & Gardam, M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70029-4 · Cited by 744
Containing Pandemic Influenza with Antiviral Agents
Longini, I. M. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh092 · Cited by 705
Hayden, F. G., Fritz, R., Lobo, M. C., Alvord, W., Strober, W., & Straus, S. E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1355 · Cited by 677
Influenza: old and new threats
Palese, P. (2004) · Nature Medicine · doi:10.1038/nm1141 · Cited by 603
The impact of influenza epidemics on mortality: introducing a severity index.
Simonsen, L., Clarke, M. J., Williamson, G. D., Stroup, D. F., Arden, N. H., & Schonberger, L. B. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.12.1944 · Cited by 587
Cox, R. J., Brokstad, K. A., & Ogra, P. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01382.x · Cited by 553
Hayden, F. G., Treanor, J. J., Fritz, R. S., Lobo, M., Betts, R. F., Miller, M., Kinnersley, N., Mills, R. G., Ward, P., & Straus, S. E. (1999) · JAMA · doi:10.1001/jama.282.13.1240 · Cited by 550
Transmission of Influenza: Implications for Control in Health Care Settings
Weinstein, R. A., Bridges, C. B., Kuehnert, M. J., & Hall, C. B. (2003) · Clinical Infectious Diseases · doi:10.1086/378292 · Cited by 536
Garg, A. X., Suri, R. S., Barrowman, N., Rehman, F., Matsell, D., Rosas-Arellano, M. P., Salvadori, M., Haynes, R. B., & Clark, W. F. (2003) · JAMA · doi:10.1001/jama.290.10.1360 · Cited by 514
Clements, M. L., Betts, R. F., Tierney, E. L., & Murphy, B. R. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.24.1.157-160.1986 · Cited by 435
Human Influenza Resulting from Aerosol Inhalation
Alford, R. H., Kasel, J. A., Gerone, P. J., & Knight, V. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-122-31255 · Cited by 363
Symptom pathogenesis during acute influenza: Interleukin‐6 and Other cytokine responses
Kaiser, L., Fritz, R. S., Straus, S. E., Gubareva, L., & Hayden, F. G. (2001) · Journal of Medical Virology · doi:10.1002/jmv.1045 · Cited by 345
Meta-Analysis: Methods for Diagnosing Intravascular Device–Related Bloodstream Infection
Safdar, N., Fine, J. P., & Maki, D. G. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00011 · Cited by 329
Nonpharmaceutical Interventions for Pandemic Influenza, International Measures
World Health Organization Writing Group (2006) · Emerging Infectious Diseases · doi:10.3201/eid1201.051370 · Cited by 326
Haemagglutination-inhibiting antibody to influenza virus.
de Jong, J. C., Palache, A. M., BEYER, W. E. P., Rimmelzwaan, G. F., Boon, A. C. M., & Osterhaus, A. D. M. E. (2003) · PubMed · Cited by 319
Epstein, S. L. (2006) · The Journal of Infectious Diseases · doi:10.1086/498980 · Cited by 295
Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza
Hayden, F. G. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530280047035 · Cited by 291
TECUMSEH STUDY OF ILLNESS. XIII. INFLUENZA INFECTION AND DISEASE, 1976–1981
MONTO, A. S., KOOPMAN, J. S., & LONGINI, I. M. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114052 · Cited by 291
Treanor, J. J., Kotloff, K., Betts, R. F., Belshe, R., Newman, F., Iacuzio, D., Wittes, J., & Bryant, M. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00334-5 · Cited by 270
INHIBITION OF RESPIRATORY VIRUS INFECTION BY LOCALLY APPLIED INTERFERON
Merigan, T., Hall, T., Reed, S., & Tyrrell, D. J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90714-9 · Cited by 254
Patterns of Shedding of Myxoviruses and Paramyxoviruses in Children
Frank, A. L., Taber, L. H., Wells, C. R., Wells, J. M., Glezen, W. P., & Paredes, A. (1981) · Journal of Infectious Diseases · doi:10.1093/infdis/144.5.433 · Cited by 249
Elder, A. G., O'Donnell, B., McCruden, E. A. B., Symington, I. S., & Carman, W. F. (1996) · BMJ · doi:10.1136/bmj.313.7067.1241 · Cited by 228
Robertson, J. S., Bootman, J. S., Newman, R., Oxford, J. S., Daniels, R. S., Webster, R. G., & Schild, G. C. (1987) · Virology · doi:10.1016/0042-6822(87)90040-7 · Cited by 218
Prolonged Shedding of Multidrug-Resistant Influenza A Virus in an Immunocompromised Patient
Weinstock, D. M., Gubareva, L. V., & Zuccotti, G. (2003) · New England Journal of Medicine · doi:10.1056/nejm200302273480923 · Cited by 207
Fritz, R. S., Hayden, F. G., Calfee, D. P., Cass, L. M. R., Peng, A. W., Alvord, W. G., Strober, W., & Straus, S. E. (1999) · The Journal of Infectious Diseases · doi:10.1086/314938 · Cited by 207
How prepared is Europe for pandemic influenza? Analysis of national plans
Mounier-Jack, S., & Coker, R. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68511-5 · Cited by 199
Immunity to influenza in the elderly
Webster, R. G. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00507-1 · Cited by 188
Host cell-mediated variation in H3N2 influenza viruses
Katz, J. M., Naeve, C. W., & Webster, R. G. (1987) · Virology · doi:10.1016/0042-6822(87)90418-1 · Cited by 166
Calfee, D. P., Peng, A., Cass, L., Lobo, M., & Hayden, F. G. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1616 · Cited by 135
Carrat, F., Sahler, C., Ranger‐Rogez, S., Leruez‐Ville, M., Freymuth, F., Galès, C. L., Bungener, M., HOUSSET, B., Nicolas, M., & Rouzioux, C. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.16.1842 · Cited by 132
Self-citationBarroso, L. F., Treanor, J. J., Gubareva, L. V., & Hayden, F. G. (2005) · Antiviral Therapy · doi:10.1177/135965350501000805 · Cited by 127
Clements, M. L., O'Donnell, S., Levine, M. M., Chanock, R. M., & Murphy, B. R. (1983) · Infection and Immunity · doi:10.1128/iai.40.3.1044-1051.1983 · Cited by 123
Recognition of Homo- and Heterosubtypic Variants of Influenza A Viruses by Human CD8+ T Lymphocytes
Boon, A. C. M., de Mutsert, G., van Baarle, D., Smith, D. J., Lapedes, A. S., Fouchier, R. A. M., Sintnicolaas, K., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2453 · Cited by 122
Brown, T. A., Murphy, B. R., Radl, J., Haaijman, J. J., & Mestecky, J. F. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.22.2.259-264.1985 · Cited by 116
Seegmiller, J. E., FRIEDMANN, T., HARRISON, H. E., WONG, V., & SCHNEIDER, J. A. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-4-883 · Cited by 109
Whicher, J. T., Chambers, R. E., Higginson, J., Nashef, L. A. M., & Higgins, P. G. (1985) · Journal of Clinical Pathology · doi:10.1136/jcp.38.3.312 · Cited by 108
Nasal and otologic effects of experimental influenza A virus infection
Doyle, W. J., Buchman, C. A., Skoner, D. P., Seroky, J. T., Hayden, F., & Fireman, P. (1994) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348949410300111 · Cited by 108
VIRAL SHEDDING IN CHILDREN WITH INFLUENZA VIRUS INFECTIONS TREATED WITH NEURAMINIDASE INHIBITORS
Sato, M., Hosoya, M., Kato, K., & Suzuki, H. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000180976.81055.ce · Cited by 107
Respiratory Nitric Oxide Levels in Experimental Human Influenza
Murphy, A. W., Platts‐Mills, T. A. E., Lobo, M., & Hayden, F. G. (1998) · CHEST Journal · doi:10.1378/chest.114.2.452 · Cited by 98
Viral Shedding Patterns of Children with Influenza B Infection
Hall, C. B., Douglas, R. G., Geiman, J. M., & Meagher, M. P. (1979) · The Journal of Infectious Diseases · doi:10.1093/infdis/140.4.610 · Cited by 97
Oral Oseltamivir in Human Experimental Influenza B Infection
Hayden, F. G., Jennings, L., Robson, R. A., Schiff, G. M., Jackson, H. C., Rana, B., McClelland, G., Ipe, D., Roberts, N. A., & Ward, P. (2000) · Antiviral Therapy · doi:10.1177/135965350000500305 · Cited by 96
Wadowsky, R. M., Mietzner, S. M., Skoner, D. P., Doyle, W. J., & Fireman, P. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1153-1157.1995 · Cited by 92
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A
Reuman, P. D., Bernstein, D. I., Keefer, M. C., Young, E. C., Sherwood, J. R., & Schiff, G. M. (1989) · Antiviral Research · doi:10.1016/0166-3542(89)90018-1 · Cited by 85
Clements, M. L., Subbarao, K., Fries, L. F., et al. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.655-662.1992 · Cited by 82
The Leukocyte Response During Viral Respiratory Illness in Man
Douglas, R. G., ALFORD, R. H., CATE, T. R., & COUCH, R. B. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-3-521 · Cited by 80
Gentile, D. A., Doyle, W. J., Whiteside, T. L., Fireman, P., Hayden, F. G., & Skoner, D. P. (1998) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.5.604-608.1998 · Cited by 80
Immunosuppression During Influenza Virus Infection
Kantzler, G. B., Lauteria, S. F., Cusumano, C. L., Lee, J. D., Ganguly, R., & Waldman, R. H. (1974) · Infection and Immunity · doi:10.1128/iai.10.5.996-1002.1974 · Cited by 80
Influenza A Virus-Induced Acute Otitis Media
Buchman, C. A., Doyle, W. J., Skoner, D. P., Post, J. C., Alper, C. M., Seroky, J. T., Anderson, K. C., Preston, R. A., Hayden, F. G., Fireman, P., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.5.1348 · Cited by 79
Complement Is Activated in the Upper Respiratory Tract during Influenza Virus Infection
Bjornson, A. B., Mellencamp, M. A., & Schiff, G. M. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.5_pt_1.1062 · Cited by 74
Magnussen, C. R., Douglas, R. G., Betts, R. F., Roth, F. K., & Meagher, M. P. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.12.4.498 · Cited by 68
Walker, J. B., Hussey, E. K., Treanor, J. J., Alfred Montalvo, Jr., & Hayden, F. G. (1997) · The Journal of Infectious Diseases · doi:10.1086/514136 · Cited by 67
Attenuated influenza produced by experimental intranasal inoculation
Little, J. W., Gordon, R. D., Hall, W. J., & Roth, F. K. (1979) · Journal of Medical Virology · doi:10.1002/jmv.1890030303 · Cited by 64
Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus
Sears, S. D., & Clements, M. L. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.10.1470 · Cited by 57
Doyle, W. J., Skoner, D. P., Alper, C. M., Allen, G., Moody, S. A., Seroky, J. T., & Hayden, F. G. (1998) · The Journal of Infectious Diseases · doi:10.1086/515294 · Cited by 56
Evaluation of Amantadine in Artificially Induced A2 and B Influenza
Smorodintsev, A. A. (1970) · JAMA · doi:10.1001/jama.1970.03170350016003 · Cited by 54
Youngner, J. S., Treanor, J. J., Betts, R. F., & Whitaker-Dowling, P. A. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.3.750-754.1994 · Cited by 53
Questioning Aerosol Transmission of Influenza
Lemieux, C., Brankston, G., Gitterman, L., Hirji, Z., & Gardam, M. A. (2007) · Emerging infectious diseases · doi:10.3201/eid1301.061202 · Cited by 51
Calfee, D. P., Peng, A., Hussey, E. K., Lobo, M., & Hayden, F. G. (1999) · Antiviral Therapy · doi:10.1177/135965359900400302 · Cited by 45
Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans
Hayden, F. G., Tunkel, A. R., Treanor, J. J., Betts, R. F., Allerheiligen, S., & Harris, J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.1178 · Cited by 41
Keitel, W., Couch, R. B., Cate, T. R., Six, H. R., & Baxter, B. D. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.1.22 · Cited by 36
Treanor, J. J., Betts, R. F., Erb, S. M., Roth, F. K., & Dolin, R. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/156.2.379 · Cited by 33
Illness and Otological Changes During Upper Respiratory Virus Infection
Doyle, W. J., Alper, C. M., Buchman, C. A., Moody‐Antonio, S., Skoner, D. P., & Cohen, S. (1999) · The Laryngoscope · doi:10.1097/00005537-199902000-00027 · Cited by 26
Lower Airway Responses to Influenza A Virus in Healthy Allergic and Nonallergic Subjects
Skoner, D. P., Doyle, W. J., Seroky, J. T., & Fireman, P. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810602 · Cited by 25
Effect of Influenza A Virus Infection on Natural and Adaptive Cellular Immunity
Skoner, D. P., Whiteside, T. L., Wilson, J. W., Doyle, W. J., Herberman, R. B., & Fireman, P. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0082 · Cited by 23
Doyle, W. J., Seroky, J. T., Angelini, B. L., Gulhan, M., Skoner, D. P., & Fireman, P. (2000) · Auris Nasus Larynx · doi:10.1016/s0385-8146(00)00075-4 · Cited by 22
New Research on Influenza: Studies with Normal Volunteers
Knight, V., KASEL, J. A., ALFORD, R. H., LODA, F., MORRIS, J. A., DAVENPORT, F. M., ROBINSON, R. Q., & BUESCHER, E. L. (1965) · Annals of Internal Medicine · doi:10.7326/0003-4819-62-6-1307 · Cited by 21
Gentile, D. A., Doyle, W. J., Fireman, P., & Skoner, D. P. (2001) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62263-6 · Cited by 19
Reuman, P. D., Bernstein, D. I., Keely, S. P., Young, E. C., Sherwood, J. R., & Schiff, G. M. (1989) · Journal of Medical Virology · doi:10.1002/jmv.1890270213 · Cited by 11
Treanor, J. J., & Betts, R. F. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.2.455 · Cited by 8
Skoner, D. P., Angelini, B. L., Jones, A., Seroky, J. T., Doyle, W. J., & Fireman, P. (1996) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/s0165-5876(96)01429-2 · Cited by 6
Cited by
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903810 · Cited by 3,037
Airborne transmission of respiratory viruses
Wang, C. C., Prather, K. A., Sznitman, J., Jimenez, J. L., Lakdawala, S. S., Tufekci, Z., & Marr, L. C. (2021) · Science · doi:10.1126/science.abd9149 · Cited by 1,543
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)
Nishiura, H., Kobayashi, T., Miyama, T., Suzuki, A., Jung, S.-M., Hayashi, K., Kinoshita, R., Yang, Y., Yuan, B., Akhmetzhanov, A. R., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.020 · Cited by 1,298
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
Kwong, J. C., Schwartz, K. L., Campitelli, M. A., Chung, H., Crowcroft, N. S., Karnauchow, T., Katz, K., Ko, D. T., McGeer, A. J., McNally, D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1702090 · Cited by 1,199
Critically Ill patients with 2009 influenza A(H1N1) in Mexico
Domínguez-Cherit, G. (2009) · JAMA · doi:10.1001/jama.2009.1536 · Cited by 840
“BMI, median (IQR)b 28 (25-32) 32 (25-42) .”
Metadata
- Authors
- Carrat, F., Vergu, E., Ferguson, N. M., Lemaitre, M., Cauchemez, S., Leach, S., & Valleron, A.-J.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-29
- Volume
- 167
- Issue
- 7
- Pages
- 775-785
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2119950877
- Cited by
- 1,133
- References
- 80
- FWCI
- 59.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.